<div id="readability-page-1">NeoGenomics (NASDAQ:NEO) is scheduled to announce Q2 earnings results on Tuesday, July 29th, before market open. The consensus EPS Estimate is $0.02 (-33.3% Y/Y) and the consensus Revenue Estimate is $182.64M (+10.7% Y/Y). Over the last 2 years, NEO has beaten EPS estimates 100% of the time and has beaten revenue estimates 75% of the time. Over the...</div>

<p>NeoGenomics（纳斯达克代码：NEO）将于 7 月 29 日公布其第二季度财报，市场普遍预期每股收益（EPS）为 0.02 美元，同比下降 33.3%；预计收入为 1.8264 亿美元，同比增加 10.7%。该公司在过去两年中表现出色，100% 超出每股收益预期，75% 超出收入预期</p>

Neogenomics 2025 年第二季度财报预览